TherapeuticsMD (NSDQ:TXMD) said today that it won FDA approval for its applicator-free estradiol vaginal capsule, TX-004HR.
The soft-gel capsule is designed to treat moderate-to-severe vaginal pain experienced during sex, a symptom of vulvar and vaginal atrophy in women who have undergone menopause.
Get the full story at our sister site, Drug Delivery Business News.
The post On second try, TherapeuticsMD lands FDA nod for vaginal capsule appeared first on MassDevice.